Actavis Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for ACTAVIS INC, and what generic and branded alternatives to ACTAVIS INC drugs are available?
ACTAVIS INC has five approved drugs.
Drugs and US Patents for Actavis Inc
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Actavis Inc | ZOLEDRONIC ACID | zoledronic acid | INJECTABLE;INTRAVENOUS | 202472-001 | Mar 4, 2013 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Actavis Inc | METHOXSALEN | methoxsalen | CAPSULE;ORAL | 202603-001 | Jun 9, 2015 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
Actavis Inc | GEMCITABINE HYDROCHLORIDE | gemcitabine hydrochloride | INJECTABLE;INJECTION | 204549-002 | Apr 11, 2016 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | |||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.